Trifluoroacetic acid → HCID 57671635, compound
Reaction equation
[Cl:1][C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][N:11]=1)[N:8]([CH3:12])[C:7](=[O:13])[C:6]([C:14]([NH:16][CH2:17][C:18]([O:20]C(C)(C)C)=[O:19])=[O:15])=[C:5]2[OH:25].C(O)(C(F)(F)F)=O>>[Cl:1][C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][N:11]=1)[N:8]([CH3:12])[C:7](=[O:13])[C:6]([C:14]([NH:16][CH2:17][C:18]([OH:20])=[O:19])=[O:15])=[C:5]2[OH:25]Participants
3
Procedure
The title compound was prepared similarly to the procedure described for Example 1 (g), by treatment of tert-butyl 2-(6-chloro-4-hydroxy-1-methyl-2-oxo-1,2-dihydro-1,7-naphthyridine-3-carboxamido)acetate (Example 105 (i)) with TFA. MS (ESI, pos. ion) m/z: 310 (M+1). 1H NMR (400 MHz, DMSO-d6) δ ppm: 10.46 (s, 1 H), 8.91 (s, 1 H), 7.94 (s, 1 H), 4.15 (d, J=5.5 Hz, 2 H), 3.69 (s, 3 H).
Sources & evidence
- ORD record
- ord-f08b1f5321a345828931d163e4ea4442
- Source dataset
- uspto-grants-2011_11
- Patent number
- US08048892B2
Reaction notes
Loading…